
NTV Online Desk
September 11, 2020, 12:10 p.m.
Updated: September 11, 2020, 12:17

Soumya Swaminathan, chief scientist of the World Health Organization. Photo: Collected
The World Health Organization (WHO) is calling the trial of the Oxford University and AstraZeneca novel coronavirus vaccine a "wake-up call". But at the same time, the agency urged researchers not to be disappointed.
Saumya Swaminathan, chief scientist at the World Health Organization, told a virtual press conference at the WHO's headquarters in Geneva on Thursday that "the trial of the corona vaccine has been postponed for the time being." 'It's a wake-up call. We need to understand that there must be successes and failures in clinical development; And we have to be ready for that. "
Meanwhile, the trial of coxavirus vaccine 'Covishield' of coronavirus has also been postponed in India. The Times of India reported the news.
AstraZeneca has suspended a human trial of the coronavirus vaccine in Oxford after a volunteer fell seriously ill. The World Health Organization is interpreting this incident as a warning. But for researchers not to be disappointed, the message has been given.
Soumya Swaminathan, chief scientist at the World Health Organization, told a press briefing in Geneva yesterday, "Such incidents are bound to happen. We should not be disappointed. '
Meanwhile, the Serum Institute of India, India's partner in making 'Covishield', announced that the trial of the vaccine would be stopped after a government notice. The Serum Institute said on Thursday that it would remain closed in India until AstraZeneca resumes ticker trials. The country's central drug regulator sent a notice yesterday to the Pune Serum Institute of India to continue the trial despite the closure of the AstraZeneca Covishield trial.
AstraZeneca has stopped experimental application of the Oxford Covid-19 vaccine to humans because the volunteer fell ill. However, the serum institute of Pune still conducted trials in 16 places in India. The Central Drug Regulator has sent a notice to them and demanded accountability from them.
"The competition is against the virus," said Mike Ryan, the WHO's head of emergency services. This competition is to save lives. It is not a matter of competition between a few companies or a few countries as to who will be able to bring the vaccine to market first. 'According to Reuters, more than 26 million people worldwide are affected by corona.
Earlier, a spokesman for AstraZeneca said: "An independent committee has decided to close the trial for the time being due to security concerns during the global trial of the Oxford coronavirus tick. The trial has been put on hold as a routine procedure due to an unexplained illness during the trial.
In the case of large trials, such an illness can occur many times, but it must be investigated, said a spokesman for AstraZeneca. However, it is not known where the volunteer who fell ill is now and how serious his condition is.